Ketamine infusion for severe borderline personality disorder
Part of Mental health clinical trials.
This study tests whether repeated ketamine infusions can reduce symptoms of severe borderline personality disorder, such as emotional instability and impulsivity. It is designed for people who have not improved enough with their current treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been diagnosed with severe borderline personality disorder.
- Your current treatments (medication or therapy) have been stable for at least 4 weeks.
- You do not have a history of psychosis, bipolar disorder, or severe depression.
- You do not have serious liver or heart problems.
- You do not use ketamine regularly for recreational purposes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether ketamine (a medication) combined with a specific type of therapy called DBT can help people with treatment-resistant depression and borderline personality disorder who are having thoughts of suicide. You would receive ketamine infusions alongside structured therapy sessions over 6 months.
This study tests if intravenous ketamine can help people with treatment-resistant depression who haven't found relief from at least two other treatments. If you qualify, you'll receive ketamine infusions to see if it improves your mood.
This study combines behavioral activation therapy (a type of counseling that helps you re-engage in positive activities) with ketamine infusions to treat depression that hasn't improved with standard antidepressants. The goal is to see if adding this therapy makes ketamine work better and last longer.
This study tests whether ketamine can help reduce suicidal thoughts in people with depression. It also looks at how ketamine affects a brain receptor that may be linked to mood and stress, to learn why it might help.
This study tests whether low-dose ketamine infusions can reduce depressive symptoms in patients staying in the intensive care unit for at least 6 days. Ketamine is a medication that may work differently than standard antidepressants and could provide faster relief.
This study tests how a single dose of ketamine affects certain brain and body markers in people with severe depression. It aims to find better ways to predict who will respond to ketamine, which may help personalize depression treatment in the future.
Hear when a new Infusion of Ketamine in Severe Borderline Personality Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.